Chemotherapy of thyroid cancer. An evaluation of experience with 37 patients.
D000293:Adolescent; D000328:Adult; D000368:Aged; D000477:Alkylating Agents / Q000627:therapeutic use; D000903:Antibiotics, Antineoplastic / Q000627:therapeutic use; D000963:Antimetabolites / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D004317:Doxorubicin / Q000627:therapeutic use; D004338:Drug Combinations; D004967:Estrogens / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009362:Neoplasm Metastasis; D012075:Remission, Spontaneous; D013964:Thyroid Neoplasms / Q000188:drug therapy* / Q000401:mortality / Q000601:surgery; D014748:Vinca Alkaloids / Q000627:therapeutic use
D000477:Alkylating Agents; D000903:Antibiotics, Antineoplastic; D000963:Antimetabolites; D000970:Antineoplastic Agents; D004338:Drug Combinations; D004967:Estrogens; D014748:Vinca Alkaloids; D004317:Doxorubicin